Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Management of Organic Mitral Regurgitation: Guideline Recommendations and Controversies

  • Gurzun, Maria-Magdalena (Cardiology Department, University of Medicine and Pharmacy "Carol Davila") ;
  • Popescu, Andreea C. (Cardiology Department, University of Medicine and Pharmacy "Carol Davila") ;
  • Ginghina, Carmen (Cardiology Department, University of Medicine and Pharmacy "Carol Davila") ;
  • Popescu, Bogdan A. (Cardiology Department, University of Medicine and Pharmacy "Carol Davila")
  • Received : 2014.11.03
  • Accepted : 2014.12.23
  • Published : 2015.03.30
⟨ Previous Next ⟩

Abstract

Mitral regurgitation (MR) represents the second most frequent valvular heart disease. The appropriate management of organic MR remains unclear in many aspects, especially in several specific clinical scenarios. This review aims to discuss the current guideline recommendations regarding the management of organic MR, while highlighting the controversial aspects encountered in daily clinical practice. The role of imaging is essential in establishing the most appropriate type of surgical treatment (repair or replace), which is based on morphological mitral valve (MV) characteristics (reparability of the valve) and local surgical expertise in valve repair. The potential advantages of 3-dimensional echocardiography in assessing the MV are discussed. Other modern imaging techniques (tissue Doppler and speckle tracking) may provide additional useful information in borderline cases. Exercise echocardiography (evaluating MR severity, pulmonary pressure, or right ventricular function) may have an important role in the management of difficult cases. Finally, the moment when surgery is no longer an option and alternative solutions should be sought is also discussed. Although in everyday clinical practice the timing of surgery is not always straightforward, some newer clinical and echocardiographic indicators can guide this decision and help improve the outcome of these patients.

Keywords

References

  1. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-43. https://doi.org/10.1016/S0195-668X(03)00201-X
  2. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11. https://doi.org/10.1016/S0140-6736(06)69208-8
  3. Delahaye JP, Gare JP, Viguier E, Delahaye F, De Gevigney G, Milon H. Natural history of severe mitral regurgitation. Eur Heart J 1991;12 Suppl B:5-9. https://doi.org/10.1093/eurheartj/12.suppl_B.5
  4. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 1999;99:400-5. https://doi.org/10.1161/01.CIR.99.3.400
  5. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 1995;91:1022-8. https://doi.org/10.1161/01.CIR.91.4.1022
  6. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2438-88. https://doi.org/10.1016/j.jacc.2014.02.537
  7. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012;33:2451-96. https://doi.org/10.1093/eurheartj/ehs109
  8. Gammie JS, Sheng S, Griffith BP, et al. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2009;87:1431-7; discussion 1437-9. https://doi.org/10.1016/j.athoracsur.2009.01.064
  9. Castillo JG, Anyanwu AC, Fuster V, Adams DH. A near 100% repair rate for mitral valve prolapse is achievable in a reference center: implications for future guidelines. J Thorac Cardiovasc Surg 2012;144:308-12. https://doi.org/10.1016/j.jtcvs.2011.12.054
  10. Castillo JG, Anyanwu AC, El-Eshmawi A, Adams DH. All anterior and bileaflet mitral valve prolapses are repairable in the modern era of reconstructive surgery. Eur J Cardiothorac Surg 2014;45:139-45; discussion 145. https://doi.org/10.1093/ejcts/ezt196
  11. Gammie JS, O’Brien SM, Griffith BP, Ferguson TB, Peterson ED. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation 2007;115:881-7. https://doi.org/10.1161/CIRCULATIONAHA.106.634436
  12. Bolling SF, Li S, O’Brien SM, Brennan JM, Prager RL, Gammie JS. Predictors of mitral valve repair: clinical and surgeon factors. Ann Thorac Surg 2010;90:1904-11; discussion 1912. https://doi.org/10.1016/j.athoracsur.2010.07.062
  13. Omran AS, Woo A, David TE, Feindel CM, Rakowski H, Siu SC. Intraoperative transesophageal echocardiography accurately predicts mitral valve anatomy and suitability for repair. J Am Soc Echocardiogr 2002;15:950-7. https://doi.org/10.1067/mje.2002.121534
  14. Lancellotti P, Tribouilloy C, Hagendorff A, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2013;14:611-44. https://doi.org/10.1093/ehjci/jet105
  15. De Bonis M, Bolling SF. Mitral valve surgery: wait and see vs. early operation. Eur Heart J 2013;34:13-9a.
  16. Vegas A, Meineri M. Core review: three-dimensional transesophageal echocardiography is a major advance for intraoperative clinical management of patients undergoing cardiac surgery: a core review. Anesth Analg 2010;110:1548-73. https://doi.org/10.1213/ANE.0b013e3181d41be7
  17. Pepi M, Tamborini G, Maltagliati A, et al. Head-to-head comparison of two- and three-dimensional transthoracic and transesophageal echocardiography in the localization of mitral valve prolapse. J Am Coll Cardiol 2006;48:2524-30. https://doi.org/10.1016/j.jacc.2006.02.079
  18. Shanks M, Siebelink HM, Delgado V, et al. Quantitative assessment of mitral regurgitation: comparison between three-dimensional transesophageal echocardiography and magnetic resonance imaging. Circ Cardiovasc Imaging 2010;3:694-700. https://doi.org/10.1161/CIRCIMAGING.110.947176
  19. Rosenhek R, Rader F, Klaar U, et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 2006;113:2238-44. https://doi.org/10.1161/CIRCULATIONAHA.105.599175
  20. Kang DH, Kim JH, Rim JH, et al. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation 2009;119:797-804. https://doi.org/10.1161/CIRCULATIONAHA.108.802314
  21. Suri RM, Vanoverschelde JL, Grigioni F, et al. Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets. JAMA 2013;310:609-16. https://doi.org/10.1001/jama.2013.8643
  22. Tietge WJ, de Heer LM, van Hessen MW, et al. Early mitral valve repair versus watchful waiting in patients with severe asymptomatic organic mitral regurgitation; rationale and design of the Dutch AMR trial, a multicenter, randomised trial. Neth Heart J 2012;20:94-101. https://doi.org/10.1007/s12471-012-0249-y
  23. Kang DH, Park SJ, Sun BJ, et al. Early surgery versus conventional treatment for asymptomatic severe mitral regurgitation: a propensity analysis. J Am Coll Cardiol 2014;63:2398-407. https://doi.org/10.1016/j.jacc.2014.02.577
  24. Pizarro R, Bazzino OO, Oberti PF, et al. Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation. J Am Coll Cardiol 2009;54:1099-106. https://doi.org/10.1016/j.jacc.2009.06.013
  25. Detaint D, Messika-Zeitoun D, Avierinos JF, et al. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation 2005;111:2391-7. https://doi.org/10.1161/01.CIR.0000164269.80908.9D
  26. Klaar U, Gabriel H, Bergler-Klein J, et al. Prognostic value of serial Btype natriuretic peptide measurement in asymptomatic organic mitral regurgitation. Eur J Heart Fail 2011;13:163-9. https://doi.org/10.1093/eurjhf/hfq189
  27. Magne J, Mahjoub H, Pierard LA, et al. Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation. Heart 2012;98:584-91. https://doi.org/10.1136/heartjnl-2011-301128
  28. Magne J, Mahjoub H, Pibarot P, Pirlet C, Pierard LA, Lancellotti P. Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation. Eur J Heart Fail 2012;14:1293-302. https://doi.org/10.1093/eurjhf/hfs114
  29. Reisner SA, Lysyansky P, Agmon Y, Mutlak D, Lessick J, Friedman Z. Global longitudinal strain: a novel index of left ventricular systolic function. J Am Soc Echocardiogr 2004;17:630-3. https://doi.org/10.1016/j.echo.2004.02.011
  30. Beladan CC, Calin A, Rosca M, Ginghina C, Popescu BA. Left ventricular twist dynamics: principles and applications. Heart 2014;100:731-40. https://doi.org/10.1136/heartjnl-2012-302064
  31. Mascle S, Schnell F, Thebault C, et al. Predictive value of global longitudinal strain in a surgical population of organic mitral regurgitation. J Am Soc Echocardiogr 2012;25:766-72. https://doi.org/10.1016/j.echo.2012.04.009
  32. Witkowski TG, Thomas JD, Debonnaire PJ, et al. Global longitudinal strain predicts left ventricular dysfunction after mitral valve repair. Eur Heart J Cardiovasc Imaging 2013;14:69-76. https://doi.org/10.1093/ehjci/jes155
  33. Pandis D, Sengupta PP, Castillo JG, et al. Assessment of longitudinal myocardial mechanics in patients with degenerative mitral valve regurgitation predicts postoperative worsening of left ventricular systolic function. J Am Soc Echocardiogr 2014;27:627-38. https://doi.org/10.1016/j.echo.2014.02.008
  34. Moustafa SE, Kansal M, Alharthi M, Deng Y, Chandrasekaran K, Mookadam F. Prediction of incipient left ventricular dysfunction in patients with chronic primary mitral regurgitation: a velocity vector imaging study. Eur J Echocardiogr 2011;12:291-8. https://doi.org/10.1093/ejechocard/jer003
  35. Borg AN, Harrison JL, Argyle RA, Ray SG. Left ventricular torsion in primary chronic mitral regurgitation. Heart 2008;94:597-603. https://doi.org/10.1136/hrt.2007.126284
  36. Rusinaru D, Tribouilloy C, Grigioni F, et al. Left atrial size is a potent predictor of mortality in mitral regurgitation due to flail leaflets: results from a large international multicenter study. Circ Cardiovasc Imaging 2011;4:473-81. https://doi.org/10.1161/CIRCIMAGING.110.961011
  37. Le Tourneau T, Messika-Zeitoun D, Russo A, et al. Impact of left atrial volume on clinical outcome in organic mitral regurgitation. J Am Coll Cardiol 2010;56:570-8. https://doi.org/10.1016/j.jacc.2010.02.059
  38. Ring L, Rana BS, Wells FC, Kydd AC, Dutka DP. Atrial function as a guide to timing of intervention in mitral valve prolapse with mitral regurgitation. JACC Cardiovasc Imaging 2014;7:225-32. https://doi.org/10.1016/j.jcmg.2013.12.009
  39. Bonow RO. Left atrial function in mitral regurgitation: guilt by association. JACC Cardiovasc Imaging 2014;7:233-5. https://doi.org/10.1016/j.jcmg.2014.01.009
  40. Cameli M, Lisi M, Righini FM, et al. Usefulness of atrial deformation analysis to predict left atrial fibrosis and endocardial thickness in patients undergoing mitral valve operations for severe mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol 2013;111:595-601. https://doi.org/10.1016/j.amjcard.2012.10.049
  41. Ghoreishi M, Evans CF, DeFilippi CR, et al. Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. J Thorac Cardiovasc Surg 2011;142:1439-52. https://doi.org/10.1016/j.jtcvs.2011.08.030
  42. Barbieri A, Bursi F, Grigioni F, et al. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J 2011;32:751-9. https://doi.org/10.1093/eurheartj/ehq294
  43. Crawford FA Jr. Residual pulmonary artery hypertension after mitral valve replacement: size matters! J Am Coll Cardiol 2005;45:1041-2. https://doi.org/10.1016/j.jacc.2004.12.059
  44. Li M, Dumesnil JG, Mathieu P, Pibarot P. Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement. J Am Coll Cardiol 2005;45:1034-40. https://doi.org/10.1016/j.jacc.2004.10.073
  45. Walls MC, Cimino N, Bolling SF, Bach DS. Persistent pulmonary hypertension after mitral valve surgery: does surgical procedure affect outcome? J Heart Valve Dis 2008;17:1-9; discussion 9.
  46. Magne J, Lancellotti P, O'Connor K, Van de Heyning CM, Szymanski C, Pierard LA. Prediction of exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. J Am Soc Echocardiogr 2011;24:1004-12. https://doi.org/10.1016/j.echo.2011.04.003
  47. Magne J, Lancellotti P, Pierard LA. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation 2010;122:33-41. https://doi.org/10.1161/CIRCULATIONAHA.110.938241
  48. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation 2008;117:1717-31. https://doi.org/10.1161/CIRCULATIONAHA.107.653584
  49. Shiran A, Sagie A. Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol 2009;53:401-8. https://doi.org/10.1016/j.jacc.2008.09.048
  50. Kusunose K, Popovic ZB, Motoki H, Marwick TH. Prognostic significance of exercise-induced right ventricular dysfunction in asymptomatic degenerative mitral regurgitation. Circ Cardiovasc Imaging 2013;6:167-76. https://doi.org/10.1161/CIRCIMAGING.112.000162
  51. Sürder D, Pedrazzini G, Gaemperli O, et al. Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry. Heart 2013;99:1034-40. https://doi.org/10.1136/heartjnl-2012-303105
  52. Messika-Zeitoun D. Percutaneous mitral valve repair using the Mitra- Clip system: time to move forward. Heart 2013;99:975-6.
  53. Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001;122:674-81. https://doi.org/10.1067/mtc.2001.117277
  54. De Bonis M, Maisano F, La Canna G, Alfieri O. Treatment and management of mitral regurgitation. Nat Rev Cardiol 2011;9:133-46. https://doi.org/10.1038/nrcardio.2011.169
  55. Guarracino F, Baldassarri R, Ferro B, et al. Transesophageal echocardiography during $MitraClip^{(R)}$ procedure. Anesth Analg 2014;118:1188-96. https://doi.org/10.1213/ANE.0000000000000215
  56. Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 2005;46:2134-40. https://doi.org/10.1016/j.jacc.2005.07.065
  57. Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-406. https://doi.org/10.1056/NEJMoa1009355
  58. Mauri L, Foster E, Glower DD, et al. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol 2013;62:317-28. https://doi.org/10.1016/j.jacc.2013.04.030

Cited by

  1. The impact of preload on 3-dimensional deformation parameters: principal strain, twist and torsion vol.15, pp.1, 2015, https://doi.org/10.1186/s12947-017-0111-x